Psychedelic Integration Circle with Michelle Baker-Jones, Ashleigh Murphy-Beiner and Natasha Moscovici (Members Only)

  • Tue 19th Oct 2021, 7:30pm – 9:30pm UK time (UTC +01:00)
  • Online
psychedelics psychedelic therapy integration harm reduction psychedelic integration members event
Hosted by The Psychedelic Society
Activity Harm Reduction & Psychedelic Integration
Enquiries to anya@psychedelicsociety.org.uk
Add to calendar Google · ICS
Share

We are excited to offer a monthly integration circle exclusively for our members which will be led by facilitators Ashleigh Murphy-Beiner, Michelle Baker-Jones and Natasha Moscovici. Experienced in offering psychedelic integration support, Michelle and Ashleigh were both guides in the Imperial College London psilocybin for depression clinical trials. As part of their work on the trials, they guided psychedelic-assisted therapy sessions and supported people to integrate their experiences in the days, weeks and months after.

Psychedelics are powerful tools that can offer profound insight and lead to transformation. However, without proper integration which supports us to make sense of those insights or translate them into actions, it can be unclear how to bring the insights back into our everyday lives. Some psychedelic experiences are also very challenging, leaving us feeling fragile, confused or overwhelmed. Sharing all of these experiences and having others hear and understand them, can be an important part of the integration process. 

With psychedelics becoming more mainstream, we feel it is essential to create community spaces where we can support each other to make sense of our psychedelic experiences. With the guidance of our facilitators, the circle will offer a safe, non-judgmental and confidential space where open conversations can happen, so we can learn from our experiences and support each other to develop, heal and grow. 

We hope that you will join us for this intimate monthly event, to be held on the second Tuesday of each month. This integration circle will be offered exclusively to our members as a thank you for your dedication to our mission to improve education about psychedelics.

Special Considerations:

  • Please note that in order to participate you will need access to Zoom
  • We require all participants to keep their video on for the duration of the meeting
  • We also ask that under no circumstances any part of the meeting be recorded (audio or video) 
  • Further information about the format of the evening and the Zoom link will be sent via email to participants ahead of the meeting
  • The meeting will be limited to 18 participants

 

FACILITATORS

Ashleigh Murphy Beiner

Ashleigh Murphy Beiner is a mindfulness meditation teacher, who recently worked as an assistant psychologist for the Psilocybin for Depression clinical trial at Imperial College London. In this, she both guided participants through their psychedelic-assisted psychotherapy treatment and led mindfulness sessions to support participants’ longer-term integration. Ashleigh has also worked with ayahuasca supporting people’s preparation and integration in Peru, and has published research on the therapeutic potential of ayahuasca for treating depression and anxiety. Ashleigh has completed training in embodied therapeutic practices and is interested in the interdisciplinary application of psychology, science and embodied approaches to the therapeutic use of psychedelics. 

Michelle Baker-Jones

Michelle Baker-Jones is a member of the Psychedelic Research Team at Imperial College London, currently conducting research that compares psilocybin and antidepressants as a form of depression treatment. She is an integrative psychotherapeutic counsellor offering individual psychedelic integration for people who are struggling to process psychedelic experiences. She also co-facilitates a monthly psychedelic integration group, which she founded alongside Dr Rosalind Watts who led the trial with psilocybin at Imperial. Excitingly, Michelle will be taking on the role of lead therapist in these studies in the new proof-of-concept trials for DMT as a rapid onset sustained treatment for various mental health disorders, developed by Small Pharma. Her talk at Breaking Convention 2019, alongside Greg Donaldson, about psychedelic therapy through archetypal lenses can be found here: https://www.youtube.com/watch?v=HKZywjeXKQc

Natasha Moscovici

Natasha is an Integrative Transpersonal Therapist in private practice with a background that includes working with drug users in a harm reduction setting, and with asylum seekers and refugees. She has a particular interest in trauma, how we are shaped by our childhoods, shadow work, and the therapeutic use of psychedelics. Tasha is passionate about self-compassion, love of the truth, and how to be truly and fully ourselves in this world.

Refunds: Please note, we do not arrange refunds or exchanges. When possible we encourage reselling on Ticketswap.
Access: We do our best to include everyone in our events, regardless of employment or health circumstances. If you would like to attend this event but are truly unable to afford the ticket price, please do get in touch with the event organiser.

Members of the Psychedelic Society get 10% off almost all of our events.
Join from £5 a month and become part of this amazing community with invites to special events and more.

Select tickets

You must be signed in and a monthly donor to The Psychedelic Society to book tickets to this event. Sign in · Become a Member

Feedback on Harm Reduction & Psychedelic Integration

By using Dandelion, you agree to the use of cookies to allow registration, login and analytics. OK